Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. (Q40124752)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Aspirin use is associated with lower indices of liver fibrosis among adults in the United States (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

Zhenghui Gordon Jiang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Yury V Popov

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Nezam Afdhal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

L Feldbrügge

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

E B Tapper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

T Ghaziani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

S C Robson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

K J Mukamal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

7 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

734-743

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26749582%20AND%20SRC:MED&resulttype=core&format=json

Fibrosis--a common pathway to organ injury and failure

4 March 2020

cites work

1 reference

21 January 2018

1 reference

Current status of novel antifibrotic therapies in patients with chronic liver disease

21 January 2018

1 reference

Therapy for fibrotic diseases: nearing the starting line

21 January 2018

1 reference

Platelets in tissue repair: control of apoptosis and interactions with regenerative cells

21 January 2018

1 reference

Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.

21 January 2018

1 reference

Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.

21 January 2018

1 reference

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

Contemporary assessment of hepatic fibrosis

21 January 2018

1 reference

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis

21 January 2018

1 reference

Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease

21 January 2018

1 reference

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Liver fibrosis markers in alcoholic liver disease

21 January 2018

1 reference

The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases

21 January 2018

1 reference

Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States.

21 January 2018

1 reference

Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease

21 January 2018

1 reference

Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).

21 January 2018

1 reference

The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.

21 January 2018

1 reference

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

21 January 2018

1 reference

Aspirin use and pancreatic cancer mortality in a large United States cohort

21 January 2018

1 reference

Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

Aspirin as an antiplatelet drug

21 January 2018

1 reference

Aspirin for the prevention of colorectal cancer

21 January 2018

1 reference

Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis

21 January 2018

1 reference

Clinical pharmacokinetics of ibuprofen. The first 30 years

21 January 2018

1 reference

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

21 January 2018

1 reference